- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on May 29, 2026
880926295EFZPNanohybrid Composite+ Capsules B1 is an EU MDR-regulated medical device registered in EUDAMED. It is classified as Class IIa. Manufactured by Spident. Placed on the EU market in France. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
088099111173553136597(01)08809911117355
European Medical Device Nomenclature — the EU product classification assigned to this device.
Q01010103DENTAL RESTORATIVE COMPOSITESPrimary placement in France; available across 1 country total.
| Country | On market since | Until |
|---|---|---|
| FrancePrimary placement | Still on market |
KR-MF-000008691The compliance carrier: encodes the device identifier plus the production identifiers (lot, serial, dates) registered for this device.
Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
View in glossary →Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
View in glossary →Contains latex
A "contains latex" flag warns that a device contains natural rubber latex, which can trigger allergic reactions in sensitive patients.
View in glossary →CMR substance
A CMR flag warns that a device contains a substance that is carcinogenic, mutagenic or toxic to reproduction above a defined threshold.
View in glossary →Endocrine-disrupting substance
An endocrine-disruptor flag warns that a device contains a substance with endocrine-disrupting properties above a defined threshold.
View in glossary →Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
View in glossary →UDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
View in glossary →MDR risk classes
MDR risk classes rank medical devices from lowest risk (Class I) to highest (Class III), which determines how much regulatory scrutiny they face.
View in glossary →Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →Certificate health across this manufacturer's portfolio.
C587048 NoMA KORIssuedNotified body
A notified body is an independent organisation, designated by an EU country, that audits manufacturers and certifies higher-risk devices before they can be CE-marked.
880926295EFZPOn the marketNanohybrid Composite+ Capsules AO2880926295EFZPOn the marketNanohybrid Composite+ Capsules AO3880926295EFZPOn the marketNanohybrid Composite+ Capsules B2880926295EFZPOn the marketNanohybrid Composite+ Capsules C2880926295EFZPOn the marketNanohybrid Composite+ Capsules TW880926295EFZPOn the marketNo certificate specifically references this device's Basic UDI-DI.